• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC).纳米多层脂质囊泡(NMVs)可增强针对肠出血性大肠杆菌(EHEC)菌株产生的志贺毒素(Stx2a)的保护性抗体反应。
Braz J Microbiol. 2019 Jan;50(1):67-77. doi: 10.1007/s42770-018-0035-0. Epub 2018 Dec 6.
2
Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.开发一种针对肠出血性大肠杆菌 O157:H7 的金纳米颗粒疫苗。
mBio. 2019 Aug 13;10(4):e01869-19. doi: 10.1128/mBio.01869-19.
3
Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.表达无毒志贺样毒素2衍生物的肠炎沙门氏菌鼠伤寒血清型疫苗株可诱导对肠出血性大肠杆菌表达的毒素产生部分保护性免疫。
Clin Vaccine Immunol. 2010 Apr;17(4):529-36. doi: 10.1128/CVI.00495-09. Epub 2010 Feb 10.
4
Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. coli O157:H7.将 HETS 重组蛋白包埋到 PLGA 和海藻酸钠 NPs 中可提高该蛋白对大肠杆菌 O157:H7 的免疫原性。
Mol Immunol. 2019 Oct;114:612-619. doi: 10.1016/j.molimm.2019.09.015. Epub 2019 Sep 19.
5
Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.通过用志贺毒素B亚基经皮免疫来预防产志贺毒素大肠杆菌感染
Clin Vaccine Immunol. 2008 Feb;15(2):359-66. doi: 10.1128/CVI.00399-07. Epub 2007 Nov 14.
6
Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.壳聚糖纳米粒包裹 LSC 嵌合蛋白对霍乱弧菌、肠产毒性大肠埃希菌和肠出血性大肠埃希菌的免疫作用。
Microb Pathog. 2019 Sep;134:103600. doi: 10.1016/j.micpath.2019.103600. Epub 2019 Jun 14.
7
Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.含有EspA、intimin和Stx2的肠出血性大肠杆菌三价重组疫苗可诱导强烈的体液免疫反应并对小鼠提供保护。
Microbes Infect. 2009 Sep;11(10-11):835-41. doi: 10.1016/j.micinf.2009.04.024. Epub 2009 May 7.
8
A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.一种多聚-N-乙酰葡萄糖胺-志贺毒素广谱缀合物疫苗,用于产志贺毒素大肠杆菌。
mBio. 2014 Mar 25;5(2):e00974-14. doi: 10.1128/mBio.00974-14.
9
Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development.肠出血性大肠杆菌EspA-Stx2Al蛋白的融合表达及免疫原性:对疫苗开发的意义
J Microbiol. 2009 Aug;47(4):498-505. doi: 10.1007/s12275-009-0116-8. Epub 2009 Sep 9.
10
A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.一种编码肠出血性大肠杆菌志贺样毒素2 A2和B亚基的DNA疫苗在小鼠模型中对志贺毒素攻击具有保护性免疫作用。
Clin Vaccine Immunol. 2009 May;16(5):712-8. doi: 10.1128/CVI.00328-08. Epub 2009 Jan 28.

引用本文的文献

1
Revolutionizing Nanovaccines: A New Era of Immunization.变革性纳米疫苗:免疫接种的新时代。
Vaccines (Basel). 2025 Jan 27;13(2):126. doi: 10.3390/vaccines13020126.
2
Genomic Analysis of Shiga Toxin-Producing O157 Cattle and Clinical Isolates from Alberta, Canada.加拿大艾伯塔省产志贺毒素 O157 牛和临床分离株的基因组分析。
Toxins (Basel). 2022 Aug 31;14(9):603. doi: 10.3390/toxins14090603.
3
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation.纳米多层脂质囊泡促进基于蛋白的疫苗制剂诱导 SARS-CoV-2 免疫应答。
Nanomedicine. 2022 Sep;45:102595. doi: 10.1016/j.nano.2022.102595. Epub 2022 Aug 27.
4
Prophylactic vaccine delivery systems against epidemic infectious diseases.针对流行性传染病的预防性疫苗投递系统。
Adv Drug Deliv Rev. 2021 Sep;176:113867. doi: 10.1016/j.addr.2021.113867. Epub 2021 Jul 17.
5
Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing .产志贺毒素大肠埃希菌的近期治疗应用及感染策略
Front Cell Infect Microbiol. 2021 Jun 29;11:614963. doi: 10.3389/fcimb.2021.614963. eCollection 2021.
6
Topical review on nano-vaccinology: Biochemical promises and key challenges.纳米疫苗学专题综述:生化前景与关键挑战
Process Biochem. 2021 Jan;100:237-244. doi: 10.1016/j.procbio.2020.09.028. Epub 2020 Sep 28.
7
Modeling Native EHEC Outer Membrane Vesicles by Creating Synthetic Surrogates.通过创建合成替代物对天然肠出血性大肠杆菌外膜囊泡进行建模。
Microorganisms. 2020 May 6;8(5):673. doi: 10.3390/microorganisms8050673.

本文引用的文献

1
Merozoite-Protein Loaded Liposomes Protect against Challenge in Two Murine Models of Infection.载有裂殖子蛋白的脂质体在两种小鼠感染模型中可抵御攻击。
ACS Biomater Sci Eng. 2016 Dec 12;2(12):2276-2286. doi: 10.1021/acsbiomaterials.6b00492. Epub 2016 Oct 17.
2
DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins.负载DNA的阳离子脂质体可有效作为抗疟疾蛋白疫苗发挥作用。
Mol Ther Methods Clin Dev. 2017 Aug 23;7:1-10. doi: 10.1016/j.omtm.2017.08.004. eCollection 2017 Dec 15.
3
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.含有单磷酰脂质A和QS-21的脂质体可作为可溶性环子孢子蛋白疟疾疫苗FMP013的有效佐剂。
Vaccine. 2017 Jul 5;35(31):3865-3874. doi: 10.1016/j.vaccine.2017.05.070. Epub 2017 Jun 7.
4
Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.由齐墩果酸制成的多囊泡脂质体控释给药系统对体外和体内肝细胞癌的作用
Int J Nanomedicine. 2016 Jul 12;11:3111-29. doi: 10.2147/IJN.S108445. eCollection 2016.
5
Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases.先进的纳米生物材料:传染病的疫苗、诊断与治疗
Molecules. 2016 Jul 1;21(7):867. doi: 10.3390/molecules21070867.
6
Expression of Shiga toxin 2 (Stx2) in highly virulent Stx-producing Escherichia coli (STEC) carrying different anti-terminator (q) genes.携带不同抗终止子(q)基因的高毒力产志贺毒素大肠杆菌(STEC)中志贺毒素2(Stx2)的表达
Microb Pathog. 2016 Aug;97:1-8. doi: 10.1016/j.micpath.2016.05.010. Epub 2016 May 18.
7
Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS).开发针对2型志贺毒素(Stx2)的骆驼科单链抗体,其对溶血尿毒综合征(HUS)具有治疗潜力。
Sci Rep. 2016 Apr 27;6:24913. doi: 10.1038/srep24913.
8
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.用于亚单位疫苗的脂质体佐剂:亚单位抗原和免疫刺激剂的配方策略
Pharmaceutics. 2016 Mar 10;8(1):7. doi: 10.3390/pharmaceutics8010007.
9
Design of nanomaterial based systems for novel vaccine development.用于新型疫苗开发的基于纳米材料的系统设计。
Biomater Sci. 2016 May 26;4(5):785-802. doi: 10.1039/c5bm00507h. Epub 2016 Feb 19.
10
Liposomes loaded with P. falciparum merozoite-derived proteins are highly immunogenic and produce invasion-inhibiting and anti-toxin antibodies.脂质体负载恶性疟原虫裂殖子来源蛋白具有高度免疫原性,能产生抑制入侵和抗毒素抗体。
J Control Release. 2015 Nov 10;217:121-7. doi: 10.1016/j.jconrel.2015.08.045. Epub 2015 Aug 31.

纳米多层脂质囊泡(NMVs)可增强针对肠出血性大肠杆菌(EHEC)菌株产生的志贺毒素(Stx2a)的保护性抗体反应。

Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC).

作者信息

Rodrigues-Jesus M J, Fotoran W L, Cardoso R M, Araki K, Wunderlich G, Ferreira Luís C S

机构信息

Vaccine Development Laboratory, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1374, Cidade Universitária, São Paulo, SP, 05508-900, Brazil.

Unit for Drug Development and Plasmodium Molecular Biology, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

出版信息

Braz J Microbiol. 2019 Jan;50(1):67-77. doi: 10.1007/s42770-018-0035-0. Epub 2018 Dec 6.

DOI:10.1007/s42770-018-0035-0
PMID:30637647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6863297/
Abstract

Microlipid vesicles (MLV) have a broad spectrum of applications for the delivery of molecules, ranging from chemical compounds to proteins, in both in vitro and in vivo conditions. In the present study, we developed a new set of nanosize multilayer lipid vesicles (NMVs) containing a unique combination of lipids. The NMVs enable the adsorption of histidine-tagged proteins at the vesicle surface and were demonstrated to be suitable for the in vivo delivery of antigens. The NMVs contained a combination of neutral (DOPC) and anionic (DPPG) lipids in the inner membrane and an external layer composed of DOPC, cholesterol, and a nickel-containing lipid (DGS-NTA [Ni]). NMVs combined with a recombinant form of the B subunit of the Shiga toxin (rStx2B) produced by certain enterohemorragic Escherichia coli (EHEC) strains enhanced the immunogenicity of the antigen after parenteral administration to mice. Mice immunized with rStx2B-loaded NMVs elicited serum antibodies capable of neutralizing the toxic activities of the native toxin; this result was demonstrated both in vitro and in vivo. Taken together, these results demonstrated that the proposed NMVs represent an alternative for the delivery of antigens, including recombinant proteins, generated in different expression systems.

摘要

微脂质体(MLV)在体外和体内条件下,对于从化合物到蛋白质等各种分子的递送都有广泛的应用。在本研究中,我们开发了一组新的纳米级多层脂质体(NMV),其含有独特的脂质组合。NMV能够使组氨酸标签蛋白吸附在囊泡表面,并被证明适用于抗原的体内递送。NMV的内膜含有中性脂质(二油酰磷脂酰胆碱,DOPC)和阴离子脂质(二棕榈酰磷脂酰甘油,DPPG)的组合,外层由DOPC、胆固醇和含镍脂质(二硬脂酰基磷脂酰乙醇胺 - N - 三(羧甲基)氨基甲酰基 - N - (镍),DGS - NTA [Ni])组成。与某些肠出血性大肠杆菌(EHEC)菌株产生的志贺毒素B亚基重组形式(rStx2B)结合的NMV,在经肠胃外给药小鼠后增强了抗原的免疫原性。用负载rStx2B的NMV免疫的小鼠产生了能够中和天然毒素毒性活性的血清抗体;这一结果在体外和体内均得到证实。综上所述,这些结果表明,所提出的NMV代表了一种用于递送包括在不同表达系统中产生的重组蛋白在内的抗原的替代方法。